Beyond Longevity

Beyond Longevity

Download on the App Store

Beyond Longevity episodes

  • Beyond Longevity at ViVE, Genomics, Microbiome Testing, and the Future of Personalized Prevention with Brock Hay of BioAro

    In this ViVE conference bonus episode of Beyond Longevity, recorded live at the ViVE event in Los Angeles, the conversation explores how BioAro is seeking to bring different strands of personalised health data together within a single longevity platform.

    Brock Hay explains BioAro’s approach to integrating genomics, microbiome testing, biomarker analysis, AI-driven interpretation, and personalized supplementation. The central idea is that health and longevity cannot be understood through any single test alone, but require a broader and more connected picture of the individual.

    The conversation also examines one of the most important questions in modern health technology, namely data privacy. As more companies collect deeply personal biological information, the focus turns to who owns that data, how it is stored, and whether individuals truly remain in control of how it is used.

    The episode also explores how tools such as telomere testing, methylation analysis, gut microbiome testing, and athlete-focused genomics are being positioned within the wider move towards preventive health. It also considers how far today’s longevity interventions can genuinely take us, and where the limits of current science and commercial promise still remain.

    Links:

    https://bioaro.com/

    linkedin.com/in/brock-hay-95204471

    00:00 Welcome to Beyond Longevity

    02:11 Meet Bio Arrow at ViVE

    02:23 All in One Longevity Platform

    05:02 Genomics Explained Simply

    07:03 Privacy and Data Security

    09:13 Genes as Prevention Tools

    11:23 Methylation and Telomeres

    12:08 Who It’s For and Pricing

    16:13 Key Longevity Biomarker

    17:40 Telomeres and Supplements

    22:13 Future of Personalized Medicine

    24:10 Gut Microbiome Testing

    28:43 Founder Story and Integration

    32:38 Research vs Consent

    37:06 Vatra Decentralized Storage

    38:58 Rapid Fire Longevity Tips

    41:06 Closing Takeaways

    43 min
  • Women’s Healthspan, Longevity Hype and Building Credible Health Businesses with Corinne Briaud Manon

    On Beyond Longevity, Corinne Briaud Manon discusses women’s healthspan through the lenses of science, consumer trust and commercial execution, drawing on her experience in major corporates and her work across Green Marlin, which advises health and longevity startups, and LongHER, a women’s healthspan community platform.

    She explains how the two initiatives connect, including how startups can test their propositions with real consumers, and outlines common early-stage pitfalls such as focusing too much on technical detail and not enough on real consumer need, lacking competitive awareness and structure, and letting passion override business discipline.

    The conversation explores what “science-backed” should really mean, why longevity is currently a kind of wild west with real credibility risks, and why women’s health needs to become a serious business if it is to address historic underinvestment.

    Corinne emphasises the importance of getting the basics right first for women, including basic health assessments, body composition, sleep, movement, strength and social connection, rather than spending blindly on superficial solutions. She also points out that access remains skewed towards the privileged and that prevention will need to be properly incentivised if it is to reach the masses.

    Instagram: @‌longher_collective

    https://www.linkedin.com/in/corinne-briaud-manon/

    00:00 Welcome and Guest Intro

    01:38 Two Ventures Overview

    02:43 Ecosystem Linking Both

    04:17 How Longher Helps Startups

    06:20 Green Marlin Origin Story

    07:39 Startup Gaps and Fixes

    11:48 Passion Versus Business

    13:00 Spotting Real Innovation

    14:44 Authenticity in Longevity Clinics

    16:53 From Lab to Market

    18:53 What Science Backed Means

    20:56 Longevity Wild West

    24:09 Why Womens Health Must Scale

    28:01 Workplace Healthspan Shift

    28:30 Workplace Health Costs

    29:19 Menopause Support Programs

    30:57 Women Led Health Startups

    32:09 Beauty Versus Longevity Hype

    33:54 Muscle Health Foundations

    35:29 Where To Begin Basics

    39:17 Stop Wasting On Superficial

    41:14 Longevity Access Inequality

    45:19 Prevention Model Shift

    50:02 Future Of Longevity Trust

    51:49 Rapid Fire Takeaways

    55:32 Closing Reflections

    58 min
  • From Lab to Life: Translating Ageing Science into Real-world Solutions with Professor Lorna Harries

    Professor Lorna Harries has spent more than two decades studying why cells age and what might be done about it. In this episode, she explains one of the most overlooked mechanisms in ageing biology, RNA splicing. When cells lose control of this process, they become stressed, dysfunctional and can tip into senescence, a state that contributes to ageing across almost every organ system.

    She explains what senescent cells actually do, how the signals they release can spread damage from one tissue to another, and why calling them “zombie cells” does not come close to telling the full story. We talk about the possibility of intervening before cells reach an irreversible state, why targeting the biology of ageing itself may matter more than tackling diseases one at a time, and what meaningful rejuvenation should really look like.

    Prof Lorna also discusses the challenge of turning lab science into therapies through her spin-out SENISCA, her work with L’Oréal, and why conditions such as IPF are an important place to begin. Along the way, she addresses the tougher questions too, including how longevity science moves from promise to treatment, where the field risks drifting into hype, and whether these advances will be available to the many or only the few.

    Links:

    http://www.senisca/

    http://www.iscarna.com/

    https://teamrna.wixsite.com/harrieslab

    https://experts.exeter.ac.uk/1873-lorna-harries

    Innovate UK ICURe Programme

    https://iuk-business-connect.org.uk/programme/icure/

    00:00 Podcast Intro Guest Setup

    01:50 Meet Professor Harris Basics

    02:16 DNA RNA Explained

    03:38 RNA Splicing And Ageing

    05:48 What Senescent Cells Do

    07:38 Reversing Senescence Window

    09:01 Fat Tissue And Faster Ageing

    11:01 Splicing As Central Hallmark

    12:11 Rejuvenation Discovery Story

    13:52 From Lab To Spinout Company

    16:41 Translating Science To Products

    19:17 Therapy Targets IPF And Beyond

    21:45 Why Translation Often Fails

    23:19 Defining Real Rejuvenation

    25:14 Avoiding Hype In Longevity

    27:17 Who Is Lagging Behind

    27:37 Regulatory Mindset Shift

    28:47 Trials Built for Ageing

    29:28 Scepticism and Overhype

    31:25 Is Ageing a Disease

    32:49 Policy and Demographic Timebomb

    33:48 Advocacy and Communication

    35:24 Personal Ageing Habits

    36:24 Key Unasked Questions

    39:15 Longevity for the Rich

    41:43 Access via NHS and Patents

    45:06 Rapid Fire and Myths

    49:05 Closing Reflections

    51 min
  • ViVE Bonus: Marc Zemel on Real-Time Hemodynamic Monitoring and Early Deterioration Detection in Critical Care

    Recorded at the 2026 VIVE conference in Los Angeles, this Beyond Longevity mini-series episode features Mark Zemel, co-founder and CEO of Retia Medical, discussing the company’s hemodynamic monitoring technology that turns continuous bedside physiological signals into real-time clinical insights for high-risk surgery and critical care.

    Marc explains Retia’s aim to detect early deterioration, guide diagnosis and therapy, and avoid the unreliability, invasiveness and complexity of older tools, noting deployment in 75 US hospitals and distribution via Medtronic, plus presence in 18 countries.

    He highlights FDA clearance for Argos Infinity enterprise software, which extends insights across the hospital and to clinicians’ phones and laptops, and shares a case where rapid detection of falling stroke volume revealed bleeding during AAA repair. The conversation covers workflow-first design, interoperability, cybersecurity, regulatory strategy, and a future path from ICU to broader wards and ultimately wearables for earlier intervention and preventative care.

    00:00 Beyond Longevity Intro

    00:44 Meet Mark Zeel

    01:40 Rata Medical Mission

    02:54 Argos Infinity Launch

    03:58 Clinicians Want Real Time

    05:19 Surgery Near Miss Story

    07:20 Why Accuracy Matters

    08:42 Why Algorithms Are Hard

    10:08 From ICU To Wearables

    12:20 Scaling Distribution Globally

    13:22 Plug And Play Integration

    15:22 Wearables And Data Overload

    18:31 Alerts And Clinical Judgment

    20:16 AI As Decision Support

    21:56 US Versus Europe Markets

    23:09 Wearables Beyond EMRs

    23:57 Regulation And Cybersecurity

    25:07 FDA And AI Pathways

    26:50 Clinician Workflow Design

    29:39 Bad Data From Friction

    31:58 Open Ecosystems Future

    33:25 Prevention And Longevity

    35:46 Personal Why Wearables Matter

    39:24 From ICU To Early Detection

    41:44 Rapid Fire And Wrap

    45 min
  • Why Longer lives Are Changing Work, Business and Society, with Avivah Wittenberg-Cox

    This week’s guest is Avivah Wittenberg-Cox. Avivah advises leaders on gender and generational balance, the future of work, and the longevity economy. She hosts the podcast 4-Quarter Lives, publishes the Substack Elderberries, and writes regularly for Forbes and Harvard Business Review. She is Visiting Faculty at Oxford’s Saïd Business School, co-directs the Longevity Leadership Programme at Católica Lisbon, and has given three TED Talks.

    In this episode, Avivah and Daphna explore how longer lives are reshaping work, business, and society. Avivah argues that longevity is not just a health story but a structural shift that is forcing organisations to rethink how they are built, how careers unfold, and how different generations work together.

    She explains why the old pyramid model of the workforce is giving way to a more square demographic reality, with far more balance between younger and older generations than most institutions were designed for. That shift brings real pressure, from pensions to healthcare, but also major opportunities for businesses willing to adapt.

    The conversation looks at why older workers are still too often overlooked, what businesses lose when they fail to value experience, and why age-inclusive thinking is becoming a strategic advantage rather than a social add-on. More broadly, the episode challenges outdated assumptions about ageing and asks what it would mean to build a society that treats longer lives as a source of possibility, not decline.

    This episode is a reminder that longevity is not only changing how long we live, but how we work, lead, learn, and contribute across the course of our lives.

    https://www.avivahwittenbergcox.com/

    https://elderberries.substack.com

    https://elderberries.substack.com/podcast

    https://www.ted.com/search?q=Avivah+Wittenberg+Cox

    https://20-first.com/

    https://www.forbes.com/sites/avivahwittenbergcox/#61c5a38ebf19

    00:00 Longevity Meets Work

    02:06 Longevity Mega Trend

    03:09 Institutions Lag Behind

    05:37 From Gender To Age

    07:39 Women And Longer Lives

    10:08 Multi Stage Careers

    11:26 Rethinking Education Midlife

    15:29 Rebranding Old Age

    17:54 Opportunity And Ageism

    21:24 Fear Of Ageing And Happiness

    25:37 Goldman Sachs And AI

    27:17 Company First Mover Advantage

    28:43 Who Is Leading The Way

    29:52 Brands Embrace Pro Ageing

    30:21 Longevity In Hospitality

    31:12 Retirees As Consultants

    31:56 Why Leaders Miss Demographics

    35:29 Government Levers And Limits

    38:34 The Square Society Shift

    40:43 Measuring Longevity Readiness

    43:25 Advice Four Quarter Lives

    47:54 Designing A Four Quarter Life

    53:22 Ageing Better Than Expected

    54:46 Rapid Fire And Wrap Up

    59 min
  • NAD, Precision Health & the Science of Living Better for Longer with Dr Jin-Xiong She

    In this episode, Dr Jin-Xiong She, a scientist with more than 400 publications, over 20,000 citations, and more than $100 million in research funding, explains why he left the top tier of academic medicine to pursue something more urgent: finding better ways to detect decline early and protect healthspan before disease takes hold. He shares what nearly 100,000 NAD tests have uncovered and why he believes biomarker baselines could change the way we think about prevention.

    https://www.jinfiniti.com/

    https://www.youtube.com/@ProfJinShe

    In this episode:

    00:00 Welcome and Guest Intro

    01:47 From Genomics to Longevity

    04:18 T1D TEDDY Study Breakthroughs

    06:07 Leaving Academia for Impact

    07:37 Healthspan Over Lifespan

    10:09 TAO Test Act Optimise

    13:20 Choosing Actionable Biomarkers

    17:02 Why NAD Tops the List

    21:45 NAD Decline and Key Drivers

    25:21 Raising NAD Lifestyle vs Supplements

    27:51 Athletes' Inflammation and Low NAD

    31:54 Optimal NAD Range and Niacin Risks

    37:28 SubQ Injections vs Oral NMN Data

    41:42 Dosing and Cutting Useless Supplements

    43:52 Access Economics and Policy Ideas

    46:50 Industry Adoption and Big Names

    47:59 Supplement Market Problems

    50:17 Rapid Fire and Closing Takeaways

    52:04 Final Summary and Goodbye

    53 min
  • Why Governments Still Ignore Ageing, and What Must Change with Dr Ilia Stambler

    What does it take to turn longevity science into real-world policy? In this episode, Daphna speaks with Dr Ilia Stambler, historian of longevity, published author, Chair of the International Longevity Alliance (ILA), and Chief Science Officer and Chairman of Vetek (Seniority) Association, about why advocacy and ecosystem-building may be just as important as the science itself.

    Dr Stambler shares how the ILA has grown into a global network connecting 76 nonprofits across 66 countries, organising international conferences, and running the annual Longevity Day (1st October) and Longevity Month (October) campaigns. He points to concrete wins, including efforts to support the inclusion of ageing-related conditions in the ICD and the WHO's work programme.

    The conversation gets honest about the real barriers to progress. Dr Stambler argues the problem isn't convincing governments that ageing matters, it's getting them to treat it with urgency. Despite ageing representing one of the largest disease burdens globally, it remains chronically underfunded and deprioritised, in part because the research timelines required don't fit neatly into political cycles.

    He also reflects on the deeper intellectual questions underpinning the field: how to balance holism and reductionism, why historical perspective is essential for longevity researchers, and how the same patterns of enthusiasm, scepticism, and neglect have repeated across centuries of rejuvenation science.

    Looking ahead to 2030, Dr Stambler highlights the need for better public education, evidence-based criteria for evaluating interventions, and growing grassroots motivation, because ultimately, he believes, a longer and healthier life begins with wanting one.


    In This Episode:

    1. How the ILA operates across 66 countries and what it's achieved
    2. Why governments acknowledge ageing but still fail to act on it
    3. The long funding timelines longevity research demands — and why that's a political problem
    4. Which countries are currently leading on longevity policy
    5. Why solo science isn't enough and advocacy changes outcomes
    6. The "Death Valley of ideas" and how to get research across it
    7. Balancing holism and reductionism in longevity science
    8. Why the history of rejuvenation science keeps repeating itself
    9. What meaningful success in this field actually looks like.

    Ilia Stambler, PhD

    Chairman and CSO. Vetek (Seniority) Association – The Movement for Longevity and Quality of Life, Israel http://www.longevityisrael.org/

    Chairman. International Longevity Alliance (ILA) http://www.longevityalliance.org/

    Fellow. Department of Science, Technology and Society, Bar-Ilan University, Israel https://sts.biu.ac.il/

    Author. A History of Life-Extensionism in the Twentieth Century; Longevity Promotion: Multidisciplinary Perspectives; Healthy Longevity: Policies and Practices http://longevityhistory.com

    https://www.longevityhistory.com/about-the-author/

    00:00 Welcome and Guest Intro

    01:28 Staler Background and Mission

    03:18 What the ILA Does

    04:04 Key Wins and Campaigns

    05:25 Public Misconceptions

    07:27 Getting Governments to Act

    09:14 Funding Research Long Term

    10:49 Education and Conferences

    12:05 Which Countries Lead

    15:22 Why Advocacy Beats Solo Science

    17:38 Advocacy Success Stories

    20:48 Breaking Longevity Silos

    21:23 Holism vs Reductionism

    22:28 Why History Matters

    24:17 Death Valley of Ideas

    25:49 Rejuvenation Patterns Repeat

    27:42 Misunderstood Longevity History

    29:22 Balance and Modesty

    31:23 Measuring Real Success

    34:59 Making Longevity Policy

    36:09 Rapid Fire Takeaways

    38:58 Final Wrap Up

    41 min
  • AI, Biomarkers and the Future of Longevity Medicine, with Elio Verhoef, Co-Founder of LongevAI

    In this episode, Daphna sits down with Elio, co-founder of LongevAI, a platform using artificial intelligence to help longevity clinics analyse biomarker data, streamline documentation, and build personalised client plans.

    With a background in computer science and a lifelong passion for health optimisation, Elio offers a grounded, honest perspective on what AI in longevity medicine can do today, and where the limits still lie.

    ______________

    What We Cover

    • How LongevAI was founded and what problem it solves for longevity clinics

    • What it means to automate clinical documentation without removing the clinician from the process

    • How AI interprets biomarker data, and why speed and accuracy both play a role

    • The hallucination problem: what it is, why it happens, and how it is being managed

    • Data privacy, GDPR compliance, and anonymisation in clinical AI tools

    • The importance of human oversight, why the clinician must always approve before anything reaches the client

    • How AI and clinicians can learn from each other in a feedback loop

    • Wearable integration and the role of continuous vs snapshot data

    • Where AI in longevity is heading in two to five years, including gene therapy modelling and whole-cell simulation

    • Why younger people are beginning to engage with longevity, and what still holds them back

    About the Guest

    Elio is the co-founder of LongevAI, a software platform built for longevity clinics. He holds a double bachelor's degree in Computer Science and Information Science, and has been focused on health optimisation and AI since his teens. He co-founded LongevAI in December 2024 alongside Cosmina Druica, whom he met through a longevity meetup community in the Netherlands.

    🔗 longevai.com

    Enjoyed this episode? Please subscribe, leave a review on Apple Podcasts or Spotify, and share with anyone curious about the future of longevity medicine.

    Beyond Longevity is hosted by Daphna Stern · beyond-longevity.co.uk

    In this episode:

    00:00 Welcome and Guest Intro

    01:52 Elio Background and Origins

    04:01 What Lev AI Does

    05:06 Automating Clinic Workflows

    07:52 Speed vs Accuracy

    11:45 Oversight and Patient Trust

    12:57 Privacy and GDPR Security

    13:56 How the Model Improves

    15:06 Limits Data and Hallucinations

    21:37 Training and Integrations

    23:45 Personal Biomarker Walkthrough

    28:34 Explaining LLMs to non-tech people

    33:38 Future of AI and Longevity

    35:32 Young People and Longevity

    39:56 Rapid Fire Questions

    43:45 Wrap Up and Key Takeaways

    46 min
  • Why Do We Age? Dr Bradley Elliott on Biomarkers, Muscle, and What Longevity Science Still Doesn’t Know

    Dr Bradley Elliott — physiologist, university lecturer, and a trustee and Communications Lead at the British Society for Research on Ageing — joins host Daphna for a refreshingly honest conversation about what longevity science actually knows and what we still cannot explain.

    This episode cuts through the certainty. We talk about biomarkers and biological age, why many measurements may be tracking effects rather than causes, we discuss extracellular vesicles and the surprising limit of science. Dr Bradley discusses some of his papers and related research, and our conversation challenges much of the conventional wisdom in the longevity space.

    What we cover:

    -Why we still do not know what fundamentally causes ageing — and why every “root cause” often leads to something deeper

    -What biomarkers really measure, what they can and cannot tell you, and which markers are most worth tracking right now

    -Biological age vs chronological age: where the concept is useful, and where it gets overclaimed

    -Why muscle is one of the most underrated “health organs” in ageing — and what it supports beyond strength

    -Exercise for longevity: the evidence-based basics, plus what matters most for consistency and adherence

    -“It is not too late”: what studies in very old adults suggest about strength gains later in life

    -Extracellular vesicles: the hidden communication system between cells, and why it is getting so much attention

    -Wearables: why they can still be useful even when the numbers are not perfectly accurate

    This is a fascinating episode with someone who knows how to communicate science and make it relatable

    Links to Dr Bradley Elliot:

    - https://www.westminster.ac.uk/about-us/our-people/directory/elliott-bradley

    - https://bsra.org.uk/bradley-elliott-2/

    - https://www.bradelliott.online/

    Papers & Research Referenced

    • Perri et al. (2025) — Delphi review identifying 14 biomarkers of ageing for use in human research (co-authored by Dr Elliott)

    ' https://pubmed.ncbi.nlm.nih.gov/39708300/

    • Lady V Barrios-Silva et al. — Activin subfamily peptides and prediction of age and physical function (undergraduate-led research, University of Westminster)

    https://pubmed.ncbi.nlm.nih.gov/30178598/

    • Dr Yvoni Kyriakidou (PhD) — Exercise-induced muscle damage in young and old men; extracellular vesicle characterisation post-exercise

    https://pubmed.ncbi.nlm.nih.gov/34650440/

    • Dr Niharika Duggal (University of Birmingham) — Masters athletes and immune function; older athletes vs. age-matched non-athletes

    https://pubmed.ncbi.nlm.nih.gov/29517845/

    • Stephen Harridge (King's College London) — Resistance training in 90+ year olds; gains in muscle strength and mass in the oldest old

    https://pubmed.ncbi.nlm.nih.gov/10398199/

    • Science paper on genetic contribution to longevity — updated estimate shifting genetic contribution to ~50% (noted with editorial by Dr Elliott)

    https://www.science.org/doi/10.1126/science.adz1187

    https://theconversation.com/what-new-twins-study-reveals-about-genes-environment-and-longevity-274763

    https://www.ukbiobank.ac.uk/

    If you enjoyed this episode, we'd love it if you took 60 seconds to leave us a review on Apple Podcasts or Spotify. It genuinely helps more people find the show and means we can keep bringing you honest, science-backed conversations like this one. Thank you

    https://beyond-longevity.co.uk/

    Chapters:

    00:00 Why We Age

    01:52 Meet Bradley Elliot

    03:07 From Sports Science

    05:32 Defining Ageing

    07:03 Mechanisms And Theories

    09:29 Biomarkers Explained

    13:02 Delphi Biomarker List

    16:59 Myostatin Study Story

    21:25 Actionable Biomarkers

    26:07 Wearables And Accuracy

    27:38 Endocrine Fingerprints

    30:11 Muscle And Healthy Ageing

    33:21 Athletes And Immunity

    34:26 Muscle Mass And Healthspan

    36:36 Exercise Dose Guidelines

    39:42 Resistance Training Plateau

    40:42 Lifestyle Versus Genetics

    42:42 Muscle Damage Study

    44:44 Extracellular Vesicles Explained

    46:49 Young Blood Controversy

    50:08 Dream Research With Omics

    56:55 What People Misjudge

    58:43 It’s Never Too Late

    01:02:41 Rapid Fire And Wrap

    01:04:31 Final Takeaways

    1 hr 6 min
  • Dr Brendan Khong on Inflammaging, Regenerative Aesthetics and Skin Health

    In this episode, I sit down with Dr Brendan Khong, a London-based aesthetic physician and regenerative medicine advocate, for a practical conversation about what it really means to age well, starting with the skin, but quickly expanding into whole-body biology.

    The central theme is a shift now reshaping aesthetic medicine: moving away from surface-level fixes and toward addressing the underlying drivers of visible ageing. A key driver, Dr Brendan explains, is inflammaging, a chronic, low-grade inflammation that builds over time and accelerates both skin ageing and broader physiological decline.

    He breaks down why some conventional aesthetic approaches can backfire, particularly repeated high-heat energy treatments, which may contribute to fibrosis, uneven pigmentation, and a dull, “waxy” skin texture over time. His approach favours smarter, gentler interventions, including an anti-inflammatory 1064nm Nd:YAG laser, targeted resurfacing that can be safer across a wider range of skin types, and calming injectables such as Meso-Wharton (a peptide product derived from Wharton’s jelly) used in practice to support skin quality, texture and fine lines.

    But this is not just a conversation about devices and injectables. Dr Brendan argues that better results start with better assessment and the need to factor in gut health, supplement use, stress load, and cortisol patterns before reaching for a needle or a laser. He is also candid about timelines: collagen remodelling takes time, and unrealistic expectations are one of the biggest problems in aesthetics.

    For day-to-day longevity habits that support skin health, he highlights fundamentals that are often overlooked: exercise, stress management, avoiding very hot showers, and finding a retinoid your skin can consistently tolerate.

    Dr Brendan Khong | London's Most Sought-after Aesthetic Doctor

    Dr Brendan Khong (@drbrendankhong) • Instagram profile

    00:00 Welcome and Guest Intro

    02:06 Brandon’s Medical Journey

    03:36 Skin as an Inflammation Mirror

    07:19 Supplements and Gut Health

    10:15 Overtreatment and Inflammaging

    14:47 Anti-Inflammatory Laser Approach

    17:39 Regenerative Injectables Peptides

    21:36 Personalised Protocols and Expectations

    25:18 Why Glanine Stands Out

    25:57 Microspheres Not Clumps

    26:55 Anti-Inflammatory Collagen

    27:47 Safety Profile Focus

    28:45 Building Patient Protocols

    30:25 Longevity Over Quick Fixes

    32:17 Future Of Aesthetics

    33:41 Gentler Treatment Philosophy

    34:49 Quantum Magnetic Resonance

    36:18 Healthy Beauty Trends

    37:25 Daily Longevity Skin Tips

    40:10 Rapid Fire Longevity Qs

    45:14 Final Takeaways And Wrap

    47 min

About Beyond Longevity

From the publisher's feed

Beyond Longevity explores the science, medicine, technology, business and policy shaping longer, healthier lives. Host Daphna Stern speaks with leading researchers, clinicians, founders and experts…